Clinical Drug Experience Knowledgebase

Arsenic Poisoning (Phase 2)

Arthritis (Phase 4)

Arthritis, Psoriatic (Phase 3)

Arthritis, Rheumatoid (Phase 4)

Asthma (Phase 2)

Autism Spectrum Disorder (Phase 2)

Bowen's Disease (Phase 2)

Carcinoma (Phase 3)

Carcinoma, Hepatocellular (Phase 3)

Cataract (Phase 2)

Communicable Diseases (Phase 4)

Convalescence (Phase 2)

Dyslipidemias (Phase 4)

Head and Neck Neoplasms (Phase 4)

Hemorrhage (Phase 1)

Hepatitis (Phase 3)

Hepatitis A (Phase 3)

Hepatitis B (Phase 3)

Hepatitis B, Chronic (Phase 3)

Hepatitis, Chronic (Phase 3)

Hyperlipidemias (Phase 3)

Hyperlipoproteinemias (Phase 3)

Hyperplasia (Phase 4)

Infections (Phase 4)

Keratosis (Phase 2)

Keratosis, Actinic (Phase 2)

Leukemia (Phase 3)

Leukemia, Lymphoid (Phase 3)

Lung Diseases (Phase 2)

Lung Diseases, Obstructive (Phase 2)

Lupus Nephritis (Phase 4)

Nephritis (Phase 4)

Neurotoxicity Syndromes (Phase 3)

Pain, Postoperative (Phase 2)

Peripheral Nervous System Diseases (Phase 2)

Poisoning (Phase 2)

Postpartum Hemorrhage (Phase 1)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 3)

Prostatic Hyperplasia (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 2)

Spondylarthritis (Phase 4)

Squamous Cell Carcinoma of Head and Neck (Phase 4)

Undifferentiated Connective Tissue Diseases (Phase 2)

Urinary Bladder, Overactive (Phase 4)

Urinary Tract Infections (Phase 4)